Display Settings:

Format

Send to:

Choose Destination

    BMC Infect Dis. 2009 Oct 18;9:171.

    Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia.

    Cho JY, Kim DM, Kwon YE, Yoon SH, Lee SI.

    Department of Internal Medicine, Chosun University, College of Medicine, Republic of Korea. bconfident@hanmail.net

    BACKGROUND: Pneumocystis jirovecii, formerly named Pneumocystis carinii, is one of the most common opportunistic infections in human immunodeficiency virus (HIV)-infected patients. CASE PRESENTATIONS: We encountered two cases of spontaneous pneumomediastinum with subcutaneous emphysema in HIV-infected patients being treated for Pneumocystis jirovecii pneumonia with trimethoprim/sulfamethoxazole. CONCLUSION: Clinicians should be aware that cystic lesions and bronchiectasis can develop in spite of trimethoprim/sulfamethoxazole treatment for P. jirovecii pneumonia. The newly formed bronchiectasis and cyst formation that were noted in follow up high resolution computed tomography (HRCT) but were not visible on HRCT at admission could be risk factors for the development of pneumothorax or pneumomediastinum with subcutaneous emphysema in HIV-patients.

    PMID: 19835635 [PubMed - indexed for MEDLINE]

    PMCID: 2770472

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Trimethoprim (Proloprim®)

      Trimethoprim eliminates bacteria that cause urinary tract infections. It is used in combination with other drugs to treat certain types of pneumonia. It also is used to treat 'travelers' diarrhea.' Antibiotics will not w...